500-Bedded Odisha COVID-19 Hospital Becomes Operational in KIMS

Bhubaneswar: A 500-Bedded Odisha COVID-19 Hospital managed and run by Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar has become operational from 2nd April 2020.

Govt. of Odisha is financing equipment and operational costs through CSR policy of OMC. Naveen Patnaik, Hon’ble Chief Minister of Odisha declared the hospital operational in the presence of Dr. Achyuta Samanta, Founder, KIIT & KISS; Dr. Subrat Acharya, Pro-Chancellor, KIIT Deemed to University and Dr. Bishnu Prasad Panigrahi, CEO, KIMS today.

The Odisha COVID Hospital has 500-bed infrastructure, including 50 critical care beds. It is well-equipped with latest instruments and other facilities. The Odisha COVID Hospital is functioning from a dedicated block of KIMS having a dedicated and exclusive team of doctors, nurses, paramedics and housekeeping staff. COVID suspects as well COVID patients will have a separate entrance and exit to KIMS campus and not intermingle with non COVID patients. The Hospital has no linkage with other departments of KIMS and is led by Dr. Bishnu Prasad Panigrahi under the guidance of Dr. Subrat Acharya.

“The Hospital adheres to the standard best practices and follows WHO and ICMR guidelines. It will be functional round the clock”, informed Dr. A. Samanta.

Related Posts

Medicines that cure Us are making Our Environment Sick

Antimicrobial Resistance Campaigner makes a Fervent Appeal for Safe Disposal of Leftover Medicines New Delhi: We invariably worry about what might be the side effects of medicines on our body…

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

National Organ Transplant Games2026 set World Record in Talkatora Indoor Stadium New Delhi: The National Organ Transplant Games began on a high note in Talkatora Indoor Stadium on November 1,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

UP expands food, drug testing capacity across all 18 divisions

UP expands food, drug testing capacity across all 18 divisions

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi